---
title: 'Research Associate - Analytics, Cell & Gene Therapies at Artis BioSolutions'
canonical: 'https://feeny.ai/job/research-associate-analytics-cell-gene-therapies-artis-biosolutions-watertown-q7enzvx81qm8'
type: 'job'
last_seen: '2026-10-15'
---

# Research Associate - Analytics, Cell & Gene Therapies at Artis BioSolutions

- **Company:** Artis BioSolutions
- **Location:** Watertown, MA
- **Employment:** full-time
- **Work type:** hybrid
- **Posted:** 2026-08-06
- **Last confirmed live:** 2026-10-15
- **Apply:** https://jobs.lever.co/landmarkbio/00a51802-9782-4c94-beae-b5d10dfcc6e1

## Job description

The Analytics department at Landmark Bio/Artis BioSolutions supports a growing portfolio of advanced cell and gene therapies (CGT), including CAR-T, iPSC, AAV, LVV and synthetic DNA products. We are immediately hiring two driven Research Associates. In this role, you will develop, qualify, and execute methods for CGT product release and characterization. You will also collaborate with analytical, process, engineering, manufacturing, and compliance teams. This is a great opportunity to learn from mentors while managing analytical tasks in a fast-paced environment to test product safety, identity, potency, purity, and quality including compendial applications. These hands-on, lab-based roles require working on-site at Landmark Bio/Artis BioSolutions in Watertown, MA, with flexible schedules to support technical operations.

## Responsibilities

- PCR Testing: Develop, optimize, and transfer PCR methods (qPCR, dPCR, ddPCR) for molecular testing.
- Cell & Proteomic Assays: Support automated cell counters, cell-based cytotoxicity assays, flow cytometry, and ELISA-based testing.
- Extracellular Vesicles and Particle Analysis: Nanoparticle Tracking, Light Scattering, and Nano Flow Cytometry
- Biophysical Analysis: Run and troubleshoot UHPLC methods (Reverse Phase, Size Exclusion) for purity and residual analysis.
- Data Documentation: Maintain precise electronic lab notebooks and draft GMP technical protocols or reports.
- Lab Maintenance: Calibrate lab instrumentation, troubleshoot performance errors and handle routine equipment upkeep.
- Safety & Compliance: Follow all environmental health and safety standards while meeting regulatory guidelines.

## Qualifications

- Education: Bachelor’s or Master’s degree in Biology, Biotechnology, Molecular Biology, or a related field.
- Experience: Minimum of 1+ years of work experience, preferably in a cGMP biotechnology manufacturing setting or equivalent higher degree academic research.
- Skills: Experience with cell/gene therapy, analytical problem-solving, and strong oral and written communication.
- Work Authorization: Must possess valid, unrestricted work authorization and be available to start immediately.

To apply, submit a resume and a cover letter that specifically details your: Unrestricted work authorization status Hands-on experience in one or more relevant lab techniques (PCR, UHPLC, Cell-based or Molecular) Familiarity with cGMP and cell and gene therapy regulatory frameworks Landmark Bio/Artis BioSolutions is an Equal Opportunity, Affirmative Action employer. Minorities, women, veterans, and individuals with disabilities are encouraged to apply.

## About Artis BioSolutions

## Company Overview
- **One-liner**: Artis BioSolutions is an integrated platform for synthetic DNA production and advanced therapy manufacturing, accelerating genetic medicines from discovery through commercial GMP production.
- **Entity Type**: Private (backed by Oak HC/FT; acquired Landmark Bio in 2025)
- **Headquarters**: Carlsbad, California, United States (also operations in Watertown, MA and Bilbao, Spain)
- **Founded**: 2024
- **Founders**: Brian Neel (CEO) and Michael Houston (Co-Founder & CSO)

## Core Business
- **Primary industry**: Contract Development and Manufacturing Organization (CDMO) for genetic medicines; biotechnology
- **Target customers**: Biopharma companies developing mRNA therapies, gene editing, viral vectors, cell therapies (CAR-T, CAR-NK, iPSCs), vaccines, and emerging modalities
- **Mission**: To advance genetic medicines and biologics from early development to market by replacing fragmented supply chains with an integrated, synthetic DNA-powered platform.

## Products & Services
- **Synthetic DNA (oDNA)**: Proprietary enzymatic manufacturing of truly synthetic, plasmid-free DNA at RUO and GMP grades, delivered in 2 weeks (RUO) or 3-4 weeks (GMP) up to gram scale.
- **Cell Therapies**: Autologous and allogeneic cell therapy development and manufacturing, including CAR-T, CAR-NK, iPSCs, MSCs, and organoids.
- **Viral Vectors**: AAV and lentiviral vector production from research scale through GMP.
- **mRNA and LNP**: In vitro transcription, formulation, and translational development.
- **Emerging Modalities**: Support for extracellular vesicles, non-viral delivery platforms, and novel technologies.
- **Integrated Services**: CMC strategy, regulatory support, process and formulation development, analytical development, GMP manufacturing, and fill/finish.

## Market Standing
- **Valuation/Market Cap**: Not disclosed (private)
- **Key Metric**: Total funding undisclosed; backed by Oak HC/FT; acquired Landmark Bio in 2025 for an undisclosed sum.
- **Notable Investors/Partners**: Oak HC/FT (lead venture and growth equity firm)
- **Growth Signals**: 
  - Emerged from stealth in April 2025 with acquisition of Landmark Bio (~75 employees).
  - Combined headcount ~80 employees (as of early 2025), with LinkedIn showing +80% YoY growth.
  - Dual manufacturing sites in the US (Watertown, MA) and EU (Bilbao, Spain).
  - 2-week RUO synthetic DNA production timeline – significantly faster than industry standard.

## Competitive Advantages
- **Integrated platform** that replaces fragmented supply chains – one vendor from synthetic DNA through GMP fill/finish.
- **Proprietary enzymatic oDNA** eliminates plasmid dependency, reducing contamination risk and accelerating timelines.
- **Multi-modality capability** (mRNA, viral vectors, cell therapies, emerging) from a single infrastructure.
- **US and EU GMP manufacturing** enables global supply chain resilience.
- **Flexible engagement models** from defined-scope projects to deep co-development partnerships.

## Strategic Focus
- Build a portfolio of subsidiaries (starting with Landmark Bio) to create a single-source CDMO for complex genetic medicines.
- Reduce project timelines and manufacturing costs for customers while maintaining quality.
- Pursue additional strategic acquisitions in partnership with Oak HC/FT to expand capabilities and respond to market shifts (e.g., mRNA, gene editing).
- Scale enzymatic synthetic DNA production as a foundational technology for all genetic medicine modalities.

## Why Work Here
- **Mission-driven environment**: Directly contribute to bringing life-changing genetic therapies to patients faster.
- **Rapid growth**: Company emerged from stealth in 2025 and is actively scaling – potential for career advancement.
- **Geographic options**: Opportunities at the Carlsbad, CA headquarters, Watertown, MA (Landmark Bio site), and Bilbao, Spain.
- **Cutting-edge technology** – work with synthetic DNA, mRNA, viral vectors, cell therapy – not just a traditional CDMO.
- **Backed by top-tier investors** (Oak HC/FT) providing stability and long-term vision.
- **Culture highlights**: Small, agile team with strong scientific leadership; collaborative approach with clients; emphasis on quality and innovation.
- **Perks**: Not explicitly listed, but as a biotech CDMO, likely includes standard benefits, potential equity, and opportunities to work on groundbreaking therapies.

## Sources
1. [Artis BioSolutions Official Website](https://artisbiosolutions.com)
2. [Artis BioSolutions LinkedIn](https://linkedin.com/company/artis-biosolutions)
3. [Artis BioSolutions Leadership Page (Landmark Bio)](https://landmarkbio.com/staff-category/artis-biosolutions-leadership-team/)
4. [San Diego Business Journal – Artis BioSolutions Emerges from Stealth](https://sdbj.com/life-sciences/artis-biosolutions-emerges-from-stealth-with-acquisition/)

## Other roles at Artis BioSolutions

- [Downstream Associate Scientist (Contract 3 to 6 months)](https://feeny.ai/job/downstream-associate-scientist-contract-3-to-6-months-artis-biosolutions-kcygep0skae3) — Watertown, MA
- [Associate Director, Quality Systems](https://feeny.ai/job/associate-director-quality-systems-artis-biosolutions-watertown-bvw59taspn0w) — Watertown, MA
- [Manager, Environmental Health & Safety (EHS)](https://feeny.ai/job/manager-environmental-health-safety-ehs-artis-biosolutions-watertown-chqjw596f5p4) — Watertown, MA